samedan logo
 
 
spacer
home > pmps > winter 2002 > taking control of your terminology
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Taking Control of your Terminology

For most people, terminology does not tend to be an all-consuming obsession. They're just words, right? In the grand scheme of things, terminology hardly features up there with AIDS in Africa and the Middle East crisis as discussion points. Let's face it, if the guy next to you at the bar starts talking about terminology, you'll almost certainly look at your watch and say, "Gosh, is that time? I really must dash!"

When it comes to terminology, familiarity breeds contempt. Authors writing corporate documentation, be it marketing brochures, technical manuals, catalogues or web content, should know which terms to use. If they don't, they'd better stop authoring and do something else. So why worry about it? We need to look at two important issues - quality management and translation.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Bob Clark, Solutions Consultant with the Logos Group of Companies
Bob Clark is a Solutions Consultant with the Logos Group of Companies in Modena, Italy. Raised in California and educated in the UK, he graduated from the University of Leeds with a Joint Honours Degree in Arabic and Russian and now holds the post of Senior Lecturer in Translation Technology at the same university.

He is Joint-Editor of Language International, a publication dedicated to the dissemination of developments affecting all aspects of the multilingual documentation production process, including authoring, translation and publication. Bob also holds a directorship in the International Trade Association of Greater Chicago.

spacer
Bob Clark
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer

Grupo NotreDame Intermédica (GNDI) is the largest healthcare operator in Brazil, with 6.4 million members. Founded in 1968, it is a pioneer in preventive medicine. GNDI has a wide offer, comprising 29 hospitals, 88 clinical centers, 23 autonomous emergency rooms, 15 preventive medicine centers and 2 health centers exclusively dedicated to the over-fifties.
More info >>

White Papers

High Potency Drugs – from Molecule to Market

PCI Pharma Services

PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling requirements for any Highly Potent Active Pharmaceutical Ingredients (HPAPI) project. Backed by 30 years’ experience of managing potent molecules, PCI Pharma Services is the logical choice when selecting an outsourcing partner.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement